CMHC Pulse Blog

Explore the Latest CME Programs: Advancing Cardiovascular and Pain Management Education 

Advancing Healthcare Knowledge: Key CME Programs of 2025 

The first half of 2025 has been remarkably productive for our continuing medical education initiatives. We’re excited to highlight several innovative CME programs designed to address critical healthcare challenges and provide practical knowledge for clinicians across specialties. 

Worsening Heart Failure: New Treatment Frontiers 

Our groundbreaking program, “At the Forefront of Care for Patients with Worsening Heart Failure,” addresses the persistent challenges of heart failure management. Despite foundational therapies like beta-blockers and ACE inhibitors, heart failure continues to present suboptimal outcomes, including poor survival rates and high rehospitalization rates. 

This webcast explores how advancements in understanding heart failure pathophysiology have introduced innovative treatment options such as SGLT-2 inhibitors, sGC stimulators, and SGLT1/2 inhibitors. Designed for primary care physicians, cardiologists, and advanced practice providers, the program offers expert insights through engaging presentations and discussions. 

Explore the heart failure webcast 

Interactive MASH Education: Gaming Meets Medicine 

Our innovative “Escape Room Experience” focuses on Metabolic dysfunction-associated steatohepatitis (MASH), a complex condition often coexisting with obesity, diabetes, and cardiovascular disease. Despite established guidelines, MASH screening and management remain insufficient among healthcare professionals. 

This unique CME activity combines expert discussions with virtual escape room challenges, allowing participants to solve clinical puzzles and tackle real patient scenarios in an interactive format. The immersive experience strengthens decision-making skills while making CME education enjoyable. 

Enter the MASH Escape Room 

Dyslipidemia Management: Clinical Brief 

Our clinical brief on “Advancements in Dyslipidemia Treatments and ASCVD Risk Reduction” provides concise yet comprehensive information on managing atherosclerotic vascular disease risk. With ASCVD affecting over 127.9 million Americans and remaining the leading cause of death, this resource is invaluable. 

Developed from a presentation at the 19th CMHC Annual Congress in Boston, this brief explores how innovative lipid-lowering treatments like bempedoic acid, PCSK9 inhibitors, and combination therapies can be integrated with traditional statin treatments to improve patient outcomes. 

Read the clinical brief 

Cardiorenal Metabolic Complexities: Interactive Case Study 

Our interactive case-based monograph explores the interconnection between cardiovascular and kidney systems through a practical patient scenario. This engaging activity focuses on managing patients with cardiorenal metabolic comorbidities, presented in an easy-to-digest infographic format. 

Participants explore evidence-based guidelines, therapeutic strategies, and risk assessment tools through decision-making scenarios and expert-led discussions to enhance interdisciplinary approaches to patient care. 

Explore the interactive case study 

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.